These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11953839)

  • 1. Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy.
    Andres R; Mayordomo JI; Isla D; Marti JL; Escudero P; Filipovich E; Saenz A; Alvarez I; Polo E; Tres A
    Br J Cancer; 2002 Mar; 86(6):1017-8. PubMed ID: 11953839
    [No Abstract]   [Full Text] [Related]  

  • 2. First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
    Pectasides D; Dimopoulos MA; Aravantinos G; Kalophonos HP; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G
    Anticancer Res; 2001; 21(5):3575-80. PubMed ID: 11848526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer.
    Vassilomanolakis M; Koumakis G; Drufakou S; Aperis G; Demiri M; Barbounis V; Missitzis J; Efremidis AP
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):179-83. PubMed ID: 12647021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal side-effects of docetaxel/vinorelbine combination.
    de Matteis A; Nuzzo F; Rossi E; Landi G; Perrone F
    Lancet; 2000 Mar; 355(9209):1098-9. PubMed ID: 10744113
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel in combination with doxorubicin or vinorelbine.
    Diéras V; Fumoleau P; Kalla S; Misset JL; Azli N; Pouillart P
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S20-2. PubMed ID: 9486099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel in combination chemotherapy for metastatic breast cancer.
    Khayat D; Antoine E
    Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel/platinum combination provides quality-of-life advantage over vinorelbine/cisplatin in advanced lung cancer.
    Oncology (Williston Park); 2002 Aug; 16(8):1052. PubMed ID: 12201644
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials of new combinations of Herceptin in metastatic breast cancer.
    Thomssen C
    Anticancer Drugs; 2001 Dec; 12 Suppl 4():S19-25. PubMed ID: 11989523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of new anticancer agents in recent years in China.
    Sun Y
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():86-7. PubMed ID: 11890120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overview of vinorelbine for metastatic breast cancer].
    Adachi I
    Nihon Rinsho; 2000 Apr; 58 Suppl():271-8. PubMed ID: 11026006
    [No Abstract]   [Full Text] [Related]  

  • 11. Taxoids in combination chemotherapy for metastatic breast cancer.
    Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer.
    Campone M; Blasinska-Morawiec M; Tekiela A; Koralewski P; Pouget JC; Douville I; Brandely M
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):937-43. PubMed ID: 18751706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine/paclitaxel combination studied in treatment of metastatic breast cancer patients.
    Oncology (Williston Park); 1995 Jun; 9(6):518, 543. PubMed ID: 8719098
    [No Abstract]   [Full Text] [Related]  

  • 14. Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer.
    Miller V
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):12-4. PubMed ID: 10437745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: a phase I/II study.
    Cals L; Nouyrigat P; Valenza B; Pedinelli FJ; Juin P
    Oncology; 2004; 67(3-4):257-61. PubMed ID: 15557787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
    Chang AY; Garrow GC
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow.
    Klein JL; Hamm C; Dansey RD; Karanes C; Abella E; Cassells L; Peters WP; Baynes RD
    Bone Marrow Transplant; 2001 Dec; 28(11):1023-9. PubMed ID: 11781611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study.
    Brugnatelli S; Riccardi A; Danova M; Pugliese P; Tinelli C; Luchena G; Bernardo A; Giardina G; Fava S; Montanari G; Pedrotti C; Poli AM
    Oncol Rep; 2001; 8(4):801-5. PubMed ID: 11410787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
    Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.